Skip to main content
NCBI home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
editorial
. 1983 Jan 29;286(6362):326–327. doi: 10.1136/bmj.286.6362.326

Disequilibrium hypercalcaemia.

D J Hosking
PMCID: PMC1546908  PMID: 6402083

Full text

PDF
326

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANDERSON J., HARPER C., DENT C. E., PHILPOT G. R. Effect of cortisone on calcium metabolism in sarcoidosis with hypercalcaemia; possibly antagonistic actions of cortisone and vitamin D. Lancet. 1954 Oct 9;267(6841):720–724. doi: 10.1016/s0140-6736(54)90492-4. [DOI] [PubMed] [Google Scholar]
  2. Adams P., Chalmers T. M., Hill L. F., Truscott B. M. Idiopathic hypercalciuria and hyperparathyroidism. Br Med J. 1970 Dec 5;4(5735):582–585. doi: 10.1136/bmj.4.5735.582. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Benabe J. E., Martinez-Maldonado M. Hypercalcemic nephropathy. Arch Intern Med. 1978 May;138(5):777–779. [PubMed] [Google Scholar]
  4. Coburn J. W., Brickman A. S., Massry S. G. Medical treatment in primary and secondary hyperparathyroidism. Semin Drug Treat. 1972 Summer;2(1):117–135. [PubMed] [Google Scholar]
  5. Fillastre J. P., Humbert G., Leroy J. Treatment of acute hypercalcemia with furosemide. Curr Ther Res Clin Exp. 1973 Sep;15(9):641–649. [PubMed] [Google Scholar]
  6. Fisken R. A., Heath D. A., Bold A. M. Hypercalcaemia--a hospital survey. Q J Med. 1980 Autumn;49(196):405–418. [PubMed] [Google Scholar]
  7. Fisken R. A., Heath D. A., Somers S., Bold A. M. Hypercalcaemia in hospital patients. Clinical and diagnostic aspects. Lancet. 1981 Jan 24;1(8213):202–207. doi: 10.1016/s0140-6736(81)90071-4. [DOI] [PubMed] [Google Scholar]
  8. Fulmer D. H., Dimich A. B., Rothschild E. O., Myers W. P. Treatment of hypercalcemia. Comparison of intravenously administered phosphate, sulfate, and hydrocortisone. Arch Intern Med. 1972 Jun;129(6):923–930. doi: 10.1001/archinte.129.6.923. [DOI] [PubMed] [Google Scholar]
  9. Hosking D. J., Cowley A., Bucknall C. A. Rehydration in the treatment of severe hypercalcaemia. Q J Med. 1981 Autumn;50(200):473–481. [PubMed] [Google Scholar]
  10. Jacobs T. P., Siris E. S., Bilezikian J. P., Baquiran D. C., Shane E., Canfield R. E. Hypercalcemia of malignancy: treatment with intravenous dichloromethylene diphosphonate. Ann Intern Med. 1981 Mar;94(3):312–316. doi: 10.7326/0003-4819-94-3-312. [DOI] [PubMed] [Google Scholar]
  11. Jung A. Comparison of two parenteral diphosphonates in hypercalcemia of malignancy. Am J Med. 1982 Feb;72(2):221–226. doi: 10.1016/0002-9343(82)90813-0. [DOI] [PubMed] [Google Scholar]
  12. Kammerman S., Canfield R. E. Effect of porcine calcitonin on hypercalcemia in man. J Clin Endocrinol Metab. 1970 Jul;31(1):70–75. doi: 10.1210/jcem-31-1-70. [DOI] [PubMed] [Google Scholar]
  13. MANNHEIMER I. H. HYPERCALCEMIA OF BREAST CANCER; MANAGEMENT WITH CORTICOSTEROIDS. Cancer. 1965 Jun;18:679–691. doi: 10.1002/1097-0142(196506)18:6<679::aid-cncr2820180605>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  14. Parfitt A. M. The actions of parathyroid hormone on bone: relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone disease. Part I of IV parts: mechanisms of calcium transfer between blood and bone and their cellular basis: morphological and kinetic approaches to bone turnover. Metabolism. 1976 Jul;25(7):809–844. doi: 10.1016/0026-0495(76)90151-7. [DOI] [PubMed] [Google Scholar]
  15. Parfitt A. M. Thiazide-induced hypercalcemia in vitamin D-treated hypoparathyroidism. Ann Intern Med. 1972 Oct;77(4):557–563. doi: 10.7326/0003-4819-77-4-557. [DOI] [PubMed] [Google Scholar]
  16. Peacock M., Robertson W. G., Nordin B. E. Relation between serum and urinary calcium with particular reference to parathyroid activity. Lancet. 1969 Feb 22;1(7591):384–386. doi: 10.1016/s0140-6736(69)91353-1. [DOI] [PubMed] [Google Scholar]
  17. Raisz L. G., Yajnik C. H., Bockman R. S., Bower B. F. Comparison of commercially available parathyroid hormone immunoassays in the differential diagnosis of hypercalcemia due to primary hyperparathyroidism or malignancy. Ann Intern Med. 1979 Nov;91(5):739–740. doi: 10.7326/0003-4819-91-5-739. [DOI] [PubMed] [Google Scholar]
  18. Schweitzer V. G., Thompson N. W., Harness J. K., Nishiyama R. H. Management of severe hypercalcemia caused by primary hyperparathyroidism. Arch Surg. 1978 Apr;113(4):373–381. doi: 10.1001/archsurg.1978.01370160031004. [DOI] [PubMed] [Google Scholar]
  19. Seyberth H. W., Segre G. V., Hamet P., Sweetman B. J., Potts J. T., Jr, Oates J. A. Characterization of the group of patients with the hypercalcemia of cancer who respond to treatment with prostaglandin synthesis inhibitors. Trans Assoc Am Physicians. 1976;89:92–104. [PubMed] [Google Scholar]
  20. Silva O. L., Becker K. L. Salmon calcitonin in the treatment of hypercalcemia. Arch Intern Med. 1973 Sep;132(3):337–339. [PubMed] [Google Scholar]
  21. Slayton R. E., Shnider B. I., Elias E., Horton J., Perlia C. P. New approach to the treatment of hypercalcemia. The effect of short-term treatment with mithramycin. Clin Pharmacol Ther. 1971 Sep-Oct;12(5):833–837. doi: 10.1002/cpt1971125833. [DOI] [PubMed] [Google Scholar]
  22. Suki W. N., Eknoyan G., Rector F. C., Jr, Seldin D. W. The renal diluting and concentrating mechanism in hypercalcemia. Nephron. 1969;6(1):50–61. doi: 10.1159/000179715. [DOI] [PubMed] [Google Scholar]
  23. Suki W. N., Yium J. J., Von Minden M., Saller-Hebert C., Eknoyan G., Martinez-Maldonado M. Acute treatment of hypercalcemia with furosemide. N Engl J Med. 1970 Oct 15;283(16):836–840. doi: 10.1056/NEJM197010152831603. [DOI] [PubMed] [Google Scholar]
  24. Thalassinos N. C., Joplin G. F. Failure of corticosteroid therapy to correct the hypercalcaemia of malignant disease. Lancet. 1970 Sep 12;2(7672):537–538. doi: 10.1016/s0140-6736(70)91345-0. [DOI] [PubMed] [Google Scholar]
  25. Wisneski L. A., Croom W. P., Silva O. L., Becker K. L. Salmon calcitonin in hypercalcemia. Clin Pharmacol Ther. 1978 Aug;24(2):219–222. doi: 10.1002/cpt1978242219. [DOI] [PubMed] [Google Scholar]
  26. Wong E. T., Freier E. F. The differential diagnosis of hypercalcemia. An algorithm for more effective use of laboratory tests. JAMA. 1982 Jan 1;247(1):75–80. doi: 10.1001/jama.247.1.75. [DOI] [PubMed] [Google Scholar]
  27. van Breukelen F. J., Bijvoet O. L., van Oosterom A. T. Inhibition of osteolytic bone lesions by (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate (A.P.D.). Lancet. 1979 Apr 14;1(8120):803–805. doi: 10.1016/s0140-6736(79)91319-9. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES